The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of fixed-duration venetoclax plus obinutuzumab (VenG) on progression-free survival (PFS), and rates and duration of minimal residual disease negativity (MRD–) in previously untreated patients (pts) with chronic lymphocytic leukemia (CLL) and comorbidities.
 
Kirsten Fischer
No Relationships to Disclose
 
Othman Al-Sawaf
No Relationships to Disclose
 
Jasmin Bahlo
No Relationships to Disclose
 
Anna-Maria Fink
No Relationships to Disclose
 
Maneesh Tandon
No Relationships to Disclose
 
Mark Dixon
No Relationships to Disclose
 
Sandra Robrecht
No Relationships to Disclose
 
Kathryn Humphrey
No Relationships to Disclose
 
Sebastian Böttcher
No Relationships to Disclose
 
Eugen Tausch
No Relationships to Disclose
 
Rod Humerickhouse
No Relationships to Disclose
 
Barbara Eichhorst
No Relationships to Disclose
 
Clemens-Martin Wendtner
No Relationships to Disclose
 
Anton W. Langerak
No Relationships to Disclose
 
Karl-Anton Kreuzer
No Relationships to Disclose
 
Valentin Goede
No Relationships to Disclose
 
Stephan Stilgenbauer
No Relationships to Disclose
 
Mehrdad Mobasher
No Relationships to Disclose
 
Matthias Ritgen
No Relationships to Disclose
 
Michael J. Hallek
No Relationships to Disclose